ViGeneron Competitors and Similar CompaniesClear all
ViGeneron's competitors and similar companies include Angionetics and ToolGen.
 ViGeneron ViGeneron is a gene therapy company dedicated to developing innovative gene therapies based on AAV capsids and AAV vectors. |  Angionetics Angionetics is a company focused on the late-stage clinical development and commercialization of Generx, an angiogenic gene therapy product candidate designed for medical revascularization for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. | ||
Founding Date | Founding Date 2017 | Founding Date N/A | Founding Date 1999 |
Type | Type Private | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations Starnberg, DE HQ Planegg, DE | Locations San Diego, US HQ | Locations KR HQ |
Employees | Employees 4 | Employees N/A | Employees 5 |
For sources of this data, please see the company profile
View Company Profiles
Angionetics
HQ
San Diego, US
Angionetics is a company focused on the late-stage clinical development and commercialization of Generx, an angiogenic gene therapy product candidate designed for medical revascularization for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease.
View company